{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:34:26Z","timestamp":1781620466992,"version":"3.54.5"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03490-7","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T12:34:18Z","timestamp":1766147658000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Systemic inflammatory response index: a novel predictor for cardiovascular disease risk in patients with primary biliary cholangitis"],"prefix":"10.1186","volume":"30","author":[{"given":"Yanyan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"issue":"4","key":"3490_CR1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cdtm.2020.09.003","volume":"6","author":"H Wang","year":"2020","unstructured":"Wang H, Jing ZC. Inflammation and cardiovascular diseases. Chronic Dis Transl Med. 2020;6(4):215\u20138. https:\/\/doi.org\/10.1016\/j.cdtm.2020.09.003.","journal-title":"Chronic Dis Transl Med"},{"issue":"8","key":"3490_CR2","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.jacc.2021.12.017","volume":"79","author":"L Liberale","year":"2022","unstructured":"Liberale L, Badimon L, Montecucco F, L\u00fcscher TF, Libby P, Camici GG. Inflammation, aging, and cardiovascular disease: JACC review topic of the week. J Am Coll Cardiol. 2022;79(8):837\u201347. https:\/\/doi.org\/10.1016\/j.jacc.2021.12.017.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"3490_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.amjcard.2004.03.023","volume":"94","author":"DM Lloyd-Jones","year":"2004","unstructured":"Lloyd-Jones DM, Wilson PW, Larson MG, Beiser A, Leip EP, D\u2019Agostino RB, et al. Framingham risk score and prediction of lifetime risk for coronary heart disease. Am J Cardiol. 2004;94(1):20\u20134. https:\/\/doi.org\/10.1016\/j.amjcard.2004.03.023.","journal-title":"Am J Cardiol"},{"key":"3490_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j2099","volume":"357","author":"J Hippisley-Cox","year":"2017","unstructured":"Hippisley-Cox J, Coupland C, Brindle P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ. 2017;357:j2099. https:\/\/doi.org\/10.1136\/bmj.j2099.","journal-title":"BMJ"},{"issue":"10354","key":"3490_CR5","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S0140-6736(22)01349-6","volume":"400","author":"N Conrad","year":"2022","unstructured":"Conrad N, Verbeke G, Molenberghs G, Goetschalckx L, Callender T, Cambridge G, et al. Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK. Lancet. 2022;400(10354):733\u201343. https:\/\/doi.org\/10.1016\/S0140-6736(22)01349-6.","journal-title":"Lancet"},{"key":"3490_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41395-018-0390-3","volume":"114","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Bernstein D, Shiffman ML, Kwo P, Kim WR, Kowdley KV, et al. Diagnosis and management of primary biliary cholangitis. Am J Gastroenterol. 2019;114:48\u201363. https:\/\/doi.org\/10.1038\/s41395-018-0390-3.","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"3490_CR7","doi-asserted-by":"publisher","first-page":"S140","DOI":"10.1111\/j.1753-4887.2007.tb00352.x","volume":"65","author":"P Libby","year":"2007","unstructured":"Libby P. Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr Rev. 2007;65(12):S140\u20136. https:\/\/doi.org\/10.1111\/j.1753-4887.2007.tb00352.x.","journal-title":"Nutr Rev"},{"issue":"8","key":"3490_CR8","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1093\/eurheartj\/ehu403","volume":"36","author":"JC Mason","year":"2015","unstructured":"Mason JC, Libby P. Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions. Eur Heart J. 2015;36(8):482\u20139. https:\/\/doi.org\/10.1093\/eurheartj\/ehu403.","journal-title":"Eur Heart J"},{"issue":"2","key":"3490_CR9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1042\/BJ20131501","volume":"458","author":"M Fern\u00e1ndez-Velasco","year":"2014","unstructured":"Fern\u00e1ndez-Velasco M, Gonz\u00e1lez-Ramos S, Bosc\u00e1 L. Involvement of monocytes\/macrophages as key factors in the development and progression of cardiovascular diseases. Biochem J. 2014;458(2):187\u201393. https:\/\/doi.org\/10.1042\/BJ20131501.","journal-title":"Biochem J"},{"issue":"6","key":"3490_CR10","doi-asserted-by":"publisher","first-page":"7204","DOI":"10.18632\/oncotarget.23208","volume":"9","author":"L Chen","year":"2017","unstructured":"Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2017;9(6):7204\u201318. https:\/\/doi.org\/10.18632\/oncotarget.23208.","journal-title":"Oncotarget"},{"issue":"47","key":"3490_CR11","doi-asserted-by":"publisher","first-page":"4953","DOI":"10.1093\/eurheartj\/ehad649","volume":"44","author":"J Luo","year":"2023","unstructured":"Luo J, Thomassen JQ, Nordestgaard BG, Tybj\u00e6rg-Hansen A, Frikke-Schmidt R. Neutrophil counts and cardiovascular disease. Eur Heart J. 2023;44(47):4953\u201364. https:\/\/doi.org\/10.1093\/eurheartj\/ehad649.","journal-title":"Eur Heart J"},{"issue":"6","key":"3490_CR12","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1161\/ATVBAHA.118.310945","volume":"38","author":"C Welsh","year":"2018","unstructured":"Welsh C, Welsh P, Mark PB, Celis-Morales CA, Lewsey J, Gray SR, et al. Association of total and differential leukocyte counts with cardiovascular disease and mortality in the UK biobank. Arterioscler Thromb Vasc Biol. 2018;38(6):1415\u201323. https:\/\/doi.org\/10.1161\/ATVBAHA.118.310945.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"3490_CR13","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1186\/s12889-024-19105-5","volume":"24","author":"E Zhou","year":"2024","unstructured":"Zhou E, Wu J, Zhou X, Yin Y. Systemic inflammatory biomarkers are novel predictors of all-cause and cardiovascular mortality in individuals with osteoarthritis: a prospective cohort study using data from the NHANES. BMC Public Health. 2024;24(1):1586. https:\/\/doi.org\/10.1186\/s12889-024-19105-5.","journal-title":"BMC Public Health"},{"key":"3490_CR14","doi-asserted-by":"publisher","first-page":"1118053","DOI":"10.3389\/fimmu.2023.1118053","volume":"14","author":"S Cui","year":"2023","unstructured":"Cui S, Cao S, Chen Q, He Q, Lang R. Preoperative systemic inflammatory response index predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation. Front Immunol. 2023;14:1118053. https:\/\/doi.org\/10.3389\/fimmu.2023.1118053.","journal-title":"Front Immunol"},{"issue":"3","key":"3490_CR15","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.3390\/jcm12031128","volume":"12","author":"Y Xia","year":"2023","unstructured":"Xia Y, Xia C, Wu L, Li Z, Li H, Zhang J. Systemic immune inflammation index (SII), system inflammation response index (SIRI) and risk of all-cause mortality and cardiovascular mortality: a 20-year follow-up cohort study of 42,875 US adults. J Clin Med. 2023;12(3):1128. https:\/\/doi.org\/10.3390\/jcm12031128.","journal-title":"J Clin Med"},{"key":"3490_CR16","doi-asserted-by":"publisher","first-page":"1087345","DOI":"10.3389\/fimmu.2023.1087345","volume":"14","author":"Y Cao","year":"2023","unstructured":"Cao Y, Li P, Zhang Y, Qiu M, Li J, Ma S, et al. Association of systemic immune inflammatory index with all-cause and cause-specific mortality in hypertensive individuals: results from NHANES. Front Immunol. 2023;14:1087345. https:\/\/doi.org\/10.3389\/fimmu.2023.1087345.","journal-title":"Front Immunol"},{"issue":"1","key":"3490_CR17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12933-024-02191-5","volume":"23","author":"X Zhang","year":"2024","unstructured":"Zhang X, Wei R, Wang X, Zhang W, Li M, Ni T, et al. The neutrophil-to-lymphocyte ratio is associated with all-cause and cardiovascular mortality among individuals with hypertension. Cardiovasc Diabetol. 2024;23(1):117. https:\/\/doi.org\/10.1186\/s12933-024-02191-5.","journal-title":"Cardiovasc Diabetol"},{"issue":"18","key":"3490_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241814378","volume":"24","author":"BS Tudurachi","year":"2023","unstructured":"Tudurachi BS, Anghel L, Tudurachi A, Sasc\u0103u RA, St\u0103tescu C. Assessment of inflammatory hematological ratios (NLR, PLR, MLR, LMR and monocyte\/HDL-cholesterol ratio) in acute myocardial infarction and particularities in young patients. Int J Mol Sci. 2023;24(18):14378. https:\/\/doi.org\/10.3390\/ijms241814378.","journal-title":"Int J Mol Sci"},{"key":"3490_CR19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","volume":"67","author":"European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67:145\u201372. https:\/\/doi.org\/10.1016\/j.jhep.2017.03.022.","journal-title":"J Hepatol"},{"issue":"1","key":"3490_CR20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","volume":"17","author":"TR Einarson","year":"2018","unstructured":"Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007\u20132017. Cardiovasc Diabetol. 2018;17(1):83. https:\/\/doi.org\/10.1186\/s12933-018-0728-6.","journal-title":"Cardiovasc Diabetol"},{"issue":"23","key":"3490_CR21","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","volume":"20","author":"B Hu","year":"2014","unstructured":"Hu B, Yang XR, Xu Y, Sun YF, Sun C, Guo W, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212\u201322. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-0442.","journal-title":"Clin Cancer Res"},{"issue":"14","key":"3490_CR22","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1002\/cncr.30057","volume":"122","author":"Q Qi","year":"2016","unstructured":"Qi Q, Zhuang L, Shen Y, Geng Y, Yu S, Chen H, et al. A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy. Cancer. 2016;122(14):2158\u201367. https:\/\/doi.org\/10.1002\/cncr.30057.","journal-title":"Cancer"},{"issue":"4","key":"3490_CR23","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1136\/flgastro-2018-101124","volume":"10","author":"MI Wah-Suarez","year":"2019","unstructured":"Wah-Suarez MI, Danford CJ, Patwardhan VR, Jiang ZG, Bonder A. Hyperlipidaemia in primary biliary cholangitis: treatment, safety and efficacy. Frontline Gastroenterol. 2019;10(4):401\u20138. https:\/\/doi.org\/10.1136\/flgastro-2018-101124.","journal-title":"Frontline Gastroenterol"},{"issue":"11","key":"3490_CR24","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1111\/hepr.12452","volume":"45","author":"P Ungprasert","year":"2015","unstructured":"Ungprasert P, Wijarnpreecha K, Ahuja W, Spanuchart I, Thongprayoon C. Coronary artery disease in primary biliary cirrhosis: a systematic review and meta-analysis of observational studies. Hepatol Res. 2015;45(11):1055\u201361. https:\/\/doi.org\/10.1111\/hepr.12452.","journal-title":"Hepatol Res"},{"key":"3490_CR25","doi-asserted-by":"publisher","first-page":"1361088","DOI":"10.3389\/fcvm.2024.1361088","volume":"11","author":"Z Liu","year":"2024","unstructured":"Liu Z, Zheng L. Associations between SII, SIRI, and cardiovascular disease in obese individuals: a nationwide cross-sectional analysis. Front Cardiovasc Med. 2024;11:1361088. https:\/\/doi.org\/10.3389\/fcvm.2024.1361088.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"3490_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13098-023-01178-8","volume":"15","author":"F Kong","year":"2023","unstructured":"Kong F, Huang J, Xu C, Huang T, Wen G, Cheng W. System inflammation response index: a novel inflammatory indicator to predict all-cause and cardiovascular disease mortality in the obese population. Diabetol Metab Syndr. 2023;15(1):195. https:\/\/doi.org\/10.1186\/s13098-023-01178-8.","journal-title":"Diabetol Metab Syndr"},{"key":"3490_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinsp.2023.100301","volume":"78","author":"SH Tan","year":"2023","unstructured":"Tan SH, Zhou XL. Early-stage non-alcoholic fatty liver disease in relation to atherosclerosis and inflammation. Clinics. 2023;78:100301. https:\/\/doi.org\/10.1016\/j.clinsp.2023.100301.","journal-title":"Clinics"},{"key":"3490_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1281839","volume":"14","author":"W Dong","year":"2024","unstructured":"Dong W, Gong Y, Zhao J, Wang Y, Li B, Yang Y. A combined analysis of TyG index, SII index, and SIRI index: positive association with CHD risk and coronary atherosclerosis severity in patients with NAFLD. Front Endocrinol. 2024;14:1281839. https:\/\/doi.org\/10.3389\/fendo.2023.1281839.","journal-title":"Front Endocrinol"},{"issue":"3","key":"3490_CR29","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM. Non-alcoholic fatty liver disease-a global public health perspective. J Hepatol. 2019;70(3):531\u201344. https:\/\/doi.org\/10.1016\/j.jhep.2018.10.033.","journal-title":"J Hepatol"},{"issue":"3","key":"3490_CR30","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrgastro.2015.12","volume":"12","author":"JK Dyson","year":"2015","unstructured":"Dyson JK, Hirschfield GM, Adams DH, Beuers U, Mann DA, Lindor KD, et al. Novel therapeutic targets in primary biliary cirrhosis. Nat Rev Gastroenterol Hepatol. 2015;12(3):147\u201358. https:\/\/doi.org\/10.1038\/nrgastro.2015.12.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"3490_CR31","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.coi.2006.09.008","volume":"18","author":"K Kikly","year":"2006","unstructured":"Kikly K, Liu L, Na S, Sedgwick JD. The IL-23\/Th(17) axis: therapeutic targets for autoimmune inflammation. Curr Opin Immunol. 2006;18(6):670\u20135. https:\/\/doi.org\/10.1016\/j.coi.2006.09.008.","journal-title":"Curr Opin Immunol"},{"issue":"6","key":"3490_CR32","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/apt.70233","volume":"62","author":"H Lin","year":"2025","unstructured":"Lin H, Zheng M, Huang Y, Zhu H, Zhang L, Yang W, et al. Lymphocyte-to-monocyte ratio as a predictor of recompensation in patients with decompensated primary biliary cholangitis. Aliment Pharmacol Ther. 2025;62(6):646\u201355. https:\/\/doi.org\/10.1111\/apt.70233.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"3490_CR33","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.cyto.2013.07.005","volume":"64","author":"C Qian","year":"2013","unstructured":"Qian C, Jiang T, Zhang W, Ren C, Wang Q, Qin Q, et al. Increased IL-23 and IL-17 expression by peripheral blood cells of patients with primary biliary cirrhosis. Cytokine. 2013;64(1):172\u201380. https:\/\/doi.org\/10.1016\/j.cyto.2013.07.005.","journal-title":"Cytokine"},{"issue":"6","key":"3490_CR34","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1365-2893.2011.01561.x","volume":"19","author":"HQ Sun","year":"2012","unstructured":"Sun HQ, Zhang JY, Zhang H, Zou ZS, Wang FS, Jia JH. Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosis. J Viral Hepat. 2012;19(6):396\u2013403. https:\/\/doi.org\/10.1111\/j.1365-2893.2011.01561.x.","journal-title":"J Viral Hepat"},{"issue":"5","key":"3490_CR35","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.imbio.2012.01.008","volume":"217","author":"A Gratchev","year":"2012","unstructured":"Gratchev A, Sobenin I, Orekhov A, Kzhyshkowska J. Monocytes as a diagnostic marker of cardiovascular diseases. Immunobiology. 2012;217(5):476\u201382. https:\/\/doi.org\/10.1016\/j.imbio.2012.01.008.","journal-title":"Immunobiology"},{"issue":"1","key":"3490_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2013.09.019","volume":"63","author":"AS Jaipersad","year":"2014","unstructured":"Jaipersad AS, Lip GY, Silverman S, Shantsila E. The role of monocytes in angiogenesis and atherosclerosis. J Am Coll Cardiol. 2014;63(1):1\u201311. https:\/\/doi.org\/10.1016\/j.jacc.2013.09.019.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"3490_CR37","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00059-015-4393-1","volume":"41","author":"H Kundi","year":"2016","unstructured":"Kundi H, Kiziltunc E, Cetin M, Cicekcioglu H, Cetin ZG, Cicek G, et al. Association of monocyte\/HDL-C ratio with SYNTAX scores in patients with stable coronary artery disease. Herz. 2016;41(6):523\u20139. https:\/\/doi.org\/10.1007\/s00059-015-4393-1.","journal-title":"Herz"},{"issue":"12","key":"3490_CR38","doi-asserted-by":"publisher","first-page":"9237","DOI":"10.1002\/jcp.27028","volume":"233","author":"S Ganjali","year":"2018","unstructured":"Ganjali S, Gotto AM Jr, Ruscica M, Atkin SL, Butler AE, Banach M, et al. Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases. J Cell Physiol. 2018;233(12):9237\u201346. https:\/\/doi.org\/10.1002\/jcp.27028.","journal-title":"J Cell Physiol"},{"issue":"17","key":"3490_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179119","volume":"22","author":"H Williams","year":"2021","unstructured":"Williams H, Mack CD, Li SCH, Fletcher JP, Medbury HJ. Nature versus number: monocytes in cardiovascular disease. Int J Mol Sci. 2021;22(17):9119. https:\/\/doi.org\/10.3390\/ijms22179119.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3490_CR40","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12933-025-02721-9","volume":"24","author":"P Qin","year":"2025","unstructured":"Qin P, Ho FK, Celis-Morales CA, Pell JP. Association between systemic inflammation biomarkers and incident cardiovascular disease in 423,701 individuals: evidence from the UK biobank cohort. Cardiovasc Diabetol. 2025;24(1):162. https:\/\/doi.org\/10.1186\/s12933-025-02721-9.","journal-title":"Cardiovasc Diabetol"},{"key":"3490_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2023.156261","volume":"169","author":"H Haybar","year":"2023","unstructured":"Haybar H, Bandar B, Torfi E, Mohebbi A, Saki N. Cytokines and their role in cardiovascular diseases. Cytokine. 2023;169:156261. https:\/\/doi.org\/10.1016\/j.cyto.2023.156261.","journal-title":"Cytokine"},{"key":"3490_CR42","doi-asserted-by":"publisher","first-page":"1338025","DOI":"10.3389\/fimmu.2024.1338025","volume":"15","author":"L Gu","year":"2024","unstructured":"Gu L, Xia Z, Qing B, Wang W, Chen H, Wang J, et al. Systemic inflammatory response index (SIRI) is associated with all-cause mortality and cardiovascular mortality in population with chronic kidney disease: evidence from NHANES (2001\u20132018). Front Immunol. 2024;15:1338025. https:\/\/doi.org\/10.3389\/fimmu.2024.1338025.","journal-title":"Front Immunol"},{"issue":"1","key":"3490_CR43","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jacc.2021.10.035","volume":"79","author":"LP Dawson","year":"2022","unstructured":"Dawson LP, Lum M, Nerleker N, Nicholls SJ, Layland J. Coronary atherosclerotic plaque regression: JACC state-of-the-art review. J Am Coll Cardiol. 2022;79(1):66\u201382. https:\/\/doi.org\/10.1016\/j.jacc.2021.10.035.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"3490_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25021082","volume":"25","author":"H Zhang","year":"2024","unstructured":"Zhang H, Dhalla NS. The role of pro-inflammatory cytokines in the pathogenesis of cardiovascular disease. Int J Mol Sci. 2024;25(2):1082. https:\/\/doi.org\/10.3390\/ijms25021082.","journal-title":"Int J Mol Sci"},{"issue":"Suppl 1","key":"3490_CR45","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1093\/gerona\/glu057","volume":"69","author":"C Franceschi","year":"2014","unstructured":"Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014;69(Suppl 1):S4-9. https:\/\/doi.org\/10.1093\/gerona\/glu057.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"3490_CR46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/MCO.0000000000000243","volume":"19","author":"LJ Dominguez","year":"2016","unstructured":"Dominguez LJ, Barbagallo M. The biology of the metabolic syndrome and aging. Curr Opin Clin Nutr Metab Care. 2016;19(1):5\u201311. https:\/\/doi.org\/10.1097\/MCO.0000000000000243.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"3490_CR47","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3760\/cma.j.cn112138-20211112-00794","volume":"30","author":"Chinese Society of Hepatology Chinese Medical Association","year":"2022","unstructured":"Chinese Society of Hepatology Chinese Medical Association. Guidelines on the diagnosis and management of primary biliary cholangitis (2021). Chin J Hepatol. 2022;30:264\u201375. https:\/\/doi.org\/10.3760\/cma.j.cn112138-20211112-00794.","journal-title":"Chin J Hepatol"},{"key":"3490_CR48","doi-asserted-by":"publisher","first-page":"1184252","DOI":"10.3389\/fimmu.2023.1184252","volume":"14","author":"Y Yang","year":"2023","unstructured":"Yang Y, He X, Rojas M, Leung PSC, Gao L. Mechanism-based target therapy in primary biliary cholangitis: opportunities before liver cirrhosis? Front Immunol. 2023;14:1184252. https:\/\/doi.org\/10.3389\/fimmu.2023.1184252.","journal-title":"Front Immunol"},{"key":"3490_CR49","doi-asserted-by":"publisher","first-page":"1164202","DOI":"10.3389\/fimmu.2023.1164202","volume":"14","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Wei S, Chen L, Zhou X, Ma X. Primary biliary cholangitis: molecular pathogenesis perspectives and therapeutic potential of natural products. Front Immunol. 2023;14:1164202. https:\/\/doi.org\/10.3389\/fimmu.2023.1164202.","journal-title":"Front Immunol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03490-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03490-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03490-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T12:34:21Z","timestamp":1766147661000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-025-03490-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3490"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03490-7","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"26 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Beijing Ditan Hospital and conducted in accordance with local laws and institutional requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1245"}}